Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jan 07, 2026
AI's Decision: D-Wave Quantum (QBTS) vs. Rigetti Computing (RGTI) AI's Preference for RGTI in Universal Quantum Computing

AI's Decision: D-Wave Quantum (QBTS) vs. Rigetti Computing (RGTI) AI's Preference for RGTI in Universal Quantum Computing

Key Takeaways

An AI-driven comparison of Rigetti Computing (RGTI) and D-Wave Quantum (QBTS) points to Rigetti as the more compelling opportunity heading into 2026. The analysis highlights RGTI’s gate-based quantum architecture, which supports universal quantum computing and a wide range of complex algorithms. While D-Wave remains a leader in quantum annealing for optimization problems, Rigetti’s full-stack, gate-based approach offers greater scalability and broader long-term applications.

By 2026, Rigetti is projected to grow revenue by roughly 150% to $150 million, with earnings per share reaching $0.30. D-Wave, by comparison, is expected to double revenue to $100 million, with EPS near $0.20. Price forecasts reflect these differing growth profiles: RGTI is projected to average $31 by the end of 2026, with upside potential to $50, while QBTS is expected to average $39, with highs near $48. Although Rigetti trades at a higher forward P/E multiple, that premium reflects its greater potential as a universal quantum computing platform.

Tickeron’s AI-powered trading bots further reinforce Rigetti’s edge. Strategies focused on RGTI have delivered annualized returns of up to 279%, supported by win rates around 72%, outperforming QBTS-focused strategies that average closer to 200%. Overall, AI-driven analysis favors Rigetti for its innovation, market positioning, and superior performance in both fundamentals and algorithmic trading.

Products and Services: Rigetti Computing vs. D-Wave Quantum

Rigetti Computing and D-Wave Quantum are both pioneers in the quantum computing space, but they pursue fundamentally different technological paths. Rigetti focuses on gate-based quantum systems designed for universal applications, while D-Wave specializes in quantum annealing optimized for specific classes of problems. As of early 2026, both companies serve enterprises, research institutions, and government clients, but their solution breadth differs significantly.

Rigetti offers an integrated, full-stack quantum computing platform built around superconducting quantum processors. Its portfolio includes quantum processing units (QPUs) for research and commercial use, as well as quantum computing as a service (QCaaS) delivered through cloud access. Rigetti also provides software tools, algorithm development, benchmarking, and professional services, enabling hybrid quantum-classical workflows. In 2025, the company advanced its gate-based roadmap with new system deployments and purchase orders, reinforcing its pursuit of scalable, universal quantum advantage.

D-Wave Quantum, in contrast, focuses on annealing-based quantum computers designed to solve optimization problems efficiently. Its flagship Advantage system features more than 5,000 qubits and is supported by the Leap cloud platform and Launch development environment. D-Wave’s ecosystem emphasizes near-term commercial applications in logistics, scheduling, and finance, supported by consulting services and developer tools such as the Ocean SDK. In 2025, D-Wave expanded its Advantage roadmap and strengthened its presence in government and defense-related projects.

While D-Wave excels in delivering practical, near-term value for optimization tasks, Rigetti stands out for its versatility and long-term potential across simulation, machine learning, and advanced scientific computing. Financially, D-Wave benefits from more established commercial deployments, but Rigetti’s hybrid and full-stack strategy positions it for faster innovation and broader adoption as quantum computing matures.

AI Trading Performance: Tickeron Bots on RGTI and QBTS

Tickeron’s AI Trading Bot use advanced financial learning models to analyze real-time market data, sentiment, and technical patterns. These systems execute strategies such as momentum trading, hedging, and volatility capture—well suited for speculative and fast-moving quantum computing stocks like RGTI and QBTS.

For Rigetti, the bots have been particularly effective in capitalizing on announcements related to gate-based technology milestones and partnerships. Top-performing strategies have generated annualized returns as high as 279%, with win rates around 72%. Multi-agent strategies delivered gains exceeding 170% over shorter time frames, while volatility-focused approaches produced outsized returns on leveraged setups. Ensemble models further improved risk-adjusted performance by reducing drawdowns.

D-Wave-focused bots, while still strong, reflect the company’s more specialized market position. Average annualized returns hover around 200%, with win rates near 70%. Strategies centered on buying dips and reacting to optimization-related news perform well, but generally lag Rigetti-focused strategies in peak upside.

In direct comparison, RGTI trading strategies outperform QBTS by an estimated 30–50%, supported by stronger growth signals and higher Sharpe ratios—an advantage heading into a potentially volatile quantum market in 2026.

2026 Price Outlook for RGTI and QBTS

Price forecasts for 2026 reflect continued optimism around the quantum computing sector, with Rigetti positioned as a key beneficiary. RGTI is projected to average $31 by year-end, with a trading range between $15 and $50, driven by system deployments and accelerating revenue growth. Quarterly estimates place the stock around $25 in Q1, rising steadily to $31 by Q4.

QBTS is expected to average $39 in 2026, with a range spanning from $20 to $48, supported by ongoing milestones in annealing technology and commercial adoption. Quarterly projections suggest a gradual climb from $30 in Q1 to $39 by Q4.

Both outlooks assume stable adoption of quantum technologies, but Rigetti’s broader applicability and universal computing focus provide greater long-term upside.

Final Verdict: RGTI or QBTS?

From an AI-driven perspective, Rigetti Computing emerges as the preferred choice for 2026. Its gate-based, universal quantum architecture, full-stack platform, and stronger growth trajectory give it an edge over D-Wave’s more specialized annealing approach. While D-Wave remains well positioned for optimization-focused applications, its narrower scope limits its disruptive potential.

With RGTI projected to average $31 in 2026 and supported by AI trading strategies delivering returns of up to 279%, Rigetti stands out as the more forward-looking quantum computing play. Investors seeking exposure to optimization use cases may still favor QBTS, but those targeting scalable, universal quantum technology are more likely to align with Rigetti’s long-term vision.

Disclaimers and Limitations

Related Ticker: RGTI, QBTS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RGTI in +4.09% Uptrend, rising for three consecutive days on September 25, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RGTI advanced for three days, in 220 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RGTI as a result. In 67 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for RGTI turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

RGTI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RGTI crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RGTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

RGTI broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RGTI entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. RGTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.901) is normal, around the industry mean (7.187). P/E Ratio (0.000) is within average values for comparable stocks, (51.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. RGTI's P/S Ratio (370.370) is very high in comparison to the industry average of (51.774).

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RGTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 31.54B. The market cap for tickers in the group ranges from -0.18 to 345.52B. DELL holds the highest valuation in this group at 345.52B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 42%. QTEX experienced the highest price growth at 124%, while XTND experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 68% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 65
Price Growth Rating: 53
SMR Rating: 80
Profit Risk Rating: 86
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
RGTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ComputerProcessingHardware

Industry
N/A
Address
775 Heinz Avenue
Phone
+1 510 210-5550
Employees
164
Web
https://www.rigetti.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.